- Tel: 858.663.9055
-
Email: info@nsjbio.com
- Tel: 858.663.9055
- Email: info@nsjbio.com
Related Products
|
Galectin 1 Antibody / Immune Regulation Protein Antibody recognizes Galectin-1 (LGALS1), a member of the galectin family of beta-galactoside-binding lectins that regulates cell adhesion, migration, apoptosis, immune homeostasis, angiogenesis, and extracellular matrix interactions. Galectin-1 is widely expressed in epithelial, endothelial, stromal, and immune cell populations where it functions as a critical mediator of cellular communication and glycan-dependent signaling pathways. Through interactions with glycosylated cell surface receptors and extracellular matrix proteins, Galectin-1 influences tissue development, wound healing, inflammatory responses, and cellular differentiation.
Galectin 1 Antibody is valuable for studying the diverse biological activities of LGALS1 in both normal physiology and disease. Galectin-1 can be localized within the cytoplasm, nucleus, cell surface, and extracellular environment, allowing it to participate in multiple regulatory mechanisms. Unlike many secreted proteins, Galectin-1 lacks a classical signal peptide and is released through non-conventional secretion pathways. Its ability to form homodimers and bind beta-galactoside-containing glycoconjugates enables regulation of receptor clustering, signal transduction, and cell-cell interactions.
Galectin 1 Antibody has become increasingly important in immunology research due to the central role of Galectin-1 in immune regulation. The protein contributes to immune tolerance, modulation of inflammatory responses, and regulation of T-cell activation and survival. Expression of Galectin-1 has been associated with mechanisms that control both innate and adaptive immune responses, making LGALS1 a useful biomarker for investigations involving inflammation, autoimmune disease, infection, and immune microenvironment biology.
Galectin 1 Antibody is also widely used in cancer and angiogenesis research. Elevated Galectin-1 expression has been reported in numerous malignancies, where it may contribute to tumor progression, immune evasion, vascular remodeling, and metastatic behavior. The involvement of LGALS1 in tumor-stromal interactions and microenvironment regulation has generated significant interest in its potential as a biomarker and therapeutic target. Consequently, Galectin-1 continues to be extensively studied in oncology, vascular biology, glycobiology, and translational research applications.
This Galectin 1 Antibody, clone GAL1/1831, has been Protein Microarray Validated, providing additional confidence in specificity for the detection of LGALS1 in immunohistochemistry, western blotting, immunofluorescence, flow cytometry, and related research applications.
Researchers studying tumor immune evasion, angiogenesis, and microenvironment remodeling may also be interested in our comprehensive collection of Cancer Antibodies.
Titering of the Galectin 1 Antibody / Immune Regulation Protein Antibody may be required for optimal performance.
A human partial recombinant protein corresponding to amino acids 12-108 was used as the immunogen for the Galectin 1 antibody.
Store the Galectin 1 antibody at 2-8oC (with azide) or aliquot and store at -20oC or colder (without azide).
Galectin-1 Antibody, LGALS1 Antibody, Gal-1 Antibody, Beta-galactoside Binding Lectin Antibody, Galaptin Antibody, Lectin Galactoside-Binding Soluble 1 Antibody, HBL Antibody, Lactose-Binding Lectin 1 Antibody
Your bulk quote request has been submitted successfully!
Please contact us if you have any questions.